Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.7000
+0.0293 (4.37%)
At close: Oct 6, 2025, 4:00 PM EDT
0.7260
+0.0260 (3.71%)
After-hours: Oct 6, 2025, 7:59 PM EDT
Iterum Therapeutics Market Cap
Iterum Therapeutics has a market cap or net worth of $31.26 million as of October 6, 2025. Its market cap has increased by 26.30% in one year.
Market Cap
31.26M
Enterprise Value
50.61M
1-Year Change
26.30%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since May 25, 2018, Iterum Therapeutics's market cap has decreased from $179.38M to $31.26M, a decrease of -82.57%. That is a compound annual growth rate of -21.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 31.26M | -35.82% |
| Dec 31, 2024 | 48.70M | 84.01% |
| Dec 29, 2023 | 26.47M | 157.57% |
| Dec 30, 2022 | 10.28M | -85.65% |
| Dec 31, 2021 | 71.61M | 47.53% |
| Dec 31, 2020 | 48.54M | -27.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 764.90B |
| Johnson & Johnson | 453.59B |
| AbbVie | 405.11B |
| UnitedHealth Group | 326.89B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 232.72B |